Pharmaceutical firms feel little threat of hostile M&A

The shareholdings of major shareholders (including special representatives) in domestic listed pharmaceutical firms hovered at 10~30 percent and the majority of owner-chairmen regard their managerial control as stable, according to data compiled by Yakup Shinmoon.

By company, Yuyu Pharm's Chairman Yoo Seung-pil was reported to control the most sizable stakes of 43 percent, followed by Dongwh...